This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

What's Your Health Care Reform Play?

Stocks in this article: THC HMA HMSY ESRX

(Health care reform article updated from March 23 with the addition of multiple analysts, Wednesday news and stock market movements, and additional insight into the impact of health care reform.)

NEW YORK ( TheStreet) -- Health care reform is a political reality -- so does health care again make sense as an investment story?

The buoyant atmosphere surrounding health care reform reached its zenith on Tuesday, when President Obama signed it into law. Health care reform had been written into law in late 2009, before it was written off in the Scott Brown era, before it was resurrected.

The action in health care stocks on Monday and Tuesday was intense as a result of President Obama's victory in making the most sweeping changes in the U.S. health care systems in decades.

It's a more complicated question than the bullish sentiment since the sudden passage of health care reform alone would suggest. It's a question that, in fact, may require health care investors to assume an investment horizon stretching out as far as 2014.

Since many of the benefits from the health care reform package will not come into play until 2014, all health care investors may be placed in a boat familiar to pharmaceutical stock investors specifically, who are accustomed to wagering on a multi-year drug pipeline probabilities.

Democrats may have "found god," as some commentators have suggested, in the parliamentary tactic known as reconciliation. For investors, though, there is no divine-like revealing of the specific health stocks to worship as investment saviors in the new health care era.

The conventional wisdom dictates that with the uncertainty related to reform finally removed, it's time for health care investors to come off the sidelines.

Monday's rally was greatest in the hospital sector and with stocks linked to Medicaid coverage, while on Tuesday many of these stocks ran into resistance, having achieved 52-week high marks just a day earlier.

Big pharma long ago cut its deal in Washington D.C. to minimize negative repercussions from the health-reform effort, yet big pharma stocks were also up modestly on Monday. And the fact that big pharma cut its deal with Washington D.C. way back when is part of the problem, actually.

Timing is everything in investing. So is it the right time to get into health care just because the year-old political saga is ending?

Health care analysts said on Monday that sentiment about health care clearly changed as a result of victory for President Obama's health care reform plan. However, a change in sentiment is not equal to a change in health care-stock fundamentals.

A Lazard Capital Markets research note on Monday depicted some of the health care investing in broad brush strokes, stating that the health care reform bill "impacts sentiment more than fundamentals." Yet Lazard Capital Markets analyst Tom Gallucci also wrote, "On the surface the passage of the bill by the House lends an element of increased certainty for now in terms of the playing field for health-care providers."

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,072.21 +42.00 0.23%
S&P 500 2,090.15 +8.27 0.40%
NASDAQ 4,802.5210 +29.0490 0.61%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs